Survival Benefit of Long-Term Sorafenib Treatment in Patients with Advanced Hepatocellular Carcinoma in Indonesia: Multicenter experience

被引：0
|
作者：
Lesmana, Cosmas R. [1 ,2 ]
Gani, Rino A. [1 ]
Pakasi, Levina S. [2 ]
Hasan, Irsan [1 ]
Waspodo, Agus S. [3 ]
Siregar, Lianda [3 ]
Budi, Poernomo [4 ]
Lesmana, Laurentius A. [1 ,2 ]
机构：
[1] Cipto Mangunkusumo Hosp, Jakarta, Indonesia
[2] Medistra Hosp, Digest Dis & GI Oncol Ctr, Jakarta, Indonesia
[3] Dharmais Canc Ctr Hosp, Jakarta, Indonesia
[4] Dr Soetomo Hosp, Surabaya, Indonesia
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1389
引用
收藏
页码：866A / 867A
页数：2
相关论文
共 50 条
  • [31] Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report
    Narita, Hibiki
    Kawaratani, Hideto
    Shibamoto, Akihiko
    Takeda, Soichi
    Ozutsumi, Takahiro
    Tsuji, Yuki
    Fujinaga, Yukihisa
    Kitagawa, Koh
    Nishimura, Norihisa
    Hokuto, Daisuke
    Sho, Masayuki
    Yoshiji, Hitoshi
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2022, 15 (05) : 953 - 959
  • [32] Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report
    Hibiki Narita
    Hideto Kawaratani
    Akihiko Shibamoto
    Soichi Takeda
    Takahiro Ozutsumi
    Yuki Tsuji
    Yukihisa Fujinaga
    Koh Kitagawa
    Norihisa Nishimura
    Daisuke Hokuto
    Masayuki Sho
    Hitoshi Yoshiji
    Clinical Journal of Gastroenterology, 2022, 15 : 953 - 959
  • [33] Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis
    Hsueh, Kuan-Chun
    Lee, Cheng-Chun
    Huang, Pi-Teh
    Liang, Chih-Yu
    Yang, Shun-Fa
    CURRENT ONCOLOGY, 2023, 30 (03) : 3206 - 3216
  • [34] Predictors of sorafenib benefit in patients with hepatocellular carcinoma
    Jackson, Richard
    Psarelli, Eftychia
    Berhane, Sarah
    Johnson, Philip J.
    JOURNAL OF HEPATOLOGY, 2018, 68 (03) : 619 - 620
  • [35] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with Sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Biondetti, P.
    Pellicelli, A. M.
    Sangiovanni, A.
    Lampertico, P.
    Marignani, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S207 - S208
  • [36] Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib
    Otsuka, Taiga
    Eguchi, Yuichiro
    Kawazoe, Seiji
    Yanagita, Kimihiko
    Ario, Keisuke
    Kitahara, Kenji
    Kawasoe, Hiroaki
    Kato, Hiroyuki
    Mizuta, Toshihiko
    HEPATOLOGY RESEARCH, 2012, 42 (09) : 879 - 886
  • [37] Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib
    Wada, Y.
    Takami, Y.
    Matsushima, H.
    Ryu, T.
    Mikagi, K.
    Saitsu, H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S630 - S631
  • [38] Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments
    Kim, Hwi Young
    Park, Joong-Won
    Nam, Byung-Ho
    Kim, Hyun Keun
    Choi, Joon-Il
    Kim, Tae Hyun
    Kim, Hyun Beom
    Kim, Chang-Min
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (11) : 1612 - 1618
  • [39] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Sangiovanni, A.
    Iannicelli, E.
    Biondetti, P.
    Pellicelli, A. M.
    Miglioresi, L.
    Marchetti, P.
    Lampertico, P.
    Marignani, M.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 14 - 14
  • [40] Sorafenib for the treatment of patients with advanced hepatocellular carcinoma and alcoholic cirrhosis
    Giovanis, P.
    Vincenzi, V.
    Manuppelli, C.
    Berletti, R.
    Marcante, M.
    Ricagna, F.
    Pinto, F.
    Giusto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
12345